{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:32:03Z","timestamp":1764401523372,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.clinthera.2009.10.014","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T04:48:11Z","timestamp":1258433291000},"page":"2152-2169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model"],"prefix":"10.1016","volume":"31","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.10.014_bib1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.10.014_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.clinthera.2009.10.014_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.10.014_bib5","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine."},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2009.10.014_bib6","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1007\/s00431-002-1066-x","article-title":"Invasive pneumococcal disease in children: Geographic and temporal variations in incidence and serotype distribution","volume":"161","author":"Hausdorff","year":"2002","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.clinthera.2009.10.014_bib7","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis."},{"year":"2008","series-title":"Phase 3 data indicate investigational 13-valent vaccine may broaden protection against pneumococcal disease in children younger than two (press release)","key":"10.1016\/j.clinthera.2009.10.014_bib9"},{"year":"2009","series-title":"GlaxoSmithKline's pneumococcal vaccine, receives European authorisation (press release)","author":"Synflorix","key":"10.1016\/j.clinthera.2009.10.014_bib10"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2009.10.014_bib11","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.vaccine.2008.05.033","article-title":"Serotypes and pathogens in pae-diatric pneumonia","volume":"26","author":"Hausdorff","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised doubleblind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2009.10.014_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.vaccine.2006.10.034","article-title":"Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination\u2014a review (2002\u20132006)","volume":"25","author":"Beutels","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.inf.0000222403.42974.8b","article-title":"Cost-effectiveness of pneumococcal conjugate vaccine: Evidence from the first 5 years of use in the United States incorporating herd effects","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.clinthera.2009.10.014_bib15","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.vaccine.2009.02.102","article-title":"How to compare the efficacy of conjugate vaccines to prevent acute otitis media?","volume":"27","author":"De Wals","year":"2009","journal-title":"Vaccine."},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2009.10.014_bib16","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1016\/j.vaccine.2009.06.004","article-title":"Serotype replacement in perspective","volume":"27","author":"Dagan","year":"2009","journal-title":"Vaccine."},{"issue":"Suppl A","key":"10.1016\/j.clinthera.2009.10.014_bib17","first-page":"46A","article-title":"Pneumococcal immunization program: Cost-utility analysis for Quebec","volume":"10","author":"De Wals","year":"1999","journal-title":"CanJ Infect Dis."},{"key":"10.1016\/j.clinthera.2009.10.014_bib18","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1016\/S0264-410X(03)00361-X","article-title":"Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada","volume":"21","author":"De Wals","year":"2003","journal-title":"Vaccine."},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2009.10.014_bib19","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.clinthera.2009.10.014_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.10.014_bib21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: A matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2009.10.014_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1099\/jmm.0.45718-0","article-title":"Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999\u20132002","volume":"54","author":"Denham","year":"2005","journal-title":"J Med Microbiol."},{"journal-title":"Number of laboratory confirmed invasive pneumococcal disease cases (including meningitis) in England and Wales","year":"1996","key":"10.1016\/j.clinthera.2009.10.014_bib25"},{"key":"10.1016\/j.clinthera.2009.10.014_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2007.07.009","article-title":"Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England","volume":"55","author":"Johnson","year":"2007","journal-title":"J Infect."},{"key":"10.1016\/j.clinthera.2009.10.014_bib28","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2004.05.003","article-title":"Costeffectiveness analysis of pneumococcal conjugate vaccination in England and Wales","volume":"22","author":"Melegaro","year":"2004","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1997.03550110063038","article-title":"Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988","volume":"278","author":"McIntyre","year":"1997","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2009.10.014_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM199012133232402","article-title":"Seizures and other neurologic sequelae of bacterial meningitis in children","volume":"323","author":"Pomeroy","year":"1990","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.10.014_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/ajrccm.165.5.2105110","article-title":"Pneumococcal meningitis in the intensive care unit: Prognostic factors of clinical outcome in a series of 80 cases","volume":"165","author":"Auburtin","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.clinthera.2009.10.014_bib32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/brain\/awg113","article-title":"Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases","volume":"126","author":"Kastenbauer","year":"2003","journal-title":"Brain."},{"key":"10.1016\/j.clinthera.2009.10.014_bib33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.inf.0000148233.57296.90","article-title":"Haemophilus influenzae: A significant pathogen in acute otitis media","volume":"23","author":"Leibovitz","year":"2004","journal-title":"Pedia-trInfect DisJ."},{"year":"2004","series-title":"International Statistical Classification of Diseases and Related Health Problems","key":"10.1016\/j.clinthera.2009.10.014_bib34"},{"year":"1977","series-title":"International Statistical Classification of Diseases and Related Health Problems","key":"10.1016\/j.clinthera.2009.10.014_bib35"},{"key":"10.1016\/j.clinthera.2009.10.014_bib36","series-title":"Pneumococcal Vaccines: The Impact of Conjugate Vaccine","first-page":"95","article-title":"Epidemiology, diagnosis, and treatment of serious pneumococcal infections in children","author":"Madhi","year":"2008"},{"key":"10.1016\/j.clinthera.2009.10.014_bib37","series-title":"Pneumococcal Vaccines: The Impact of Conjugate Vaccine","first-page":"117","article-title":"Epidemiology, diagnosis, and treatment of serious pneumococcal infections in children","author":"Rubins","year":"2008"},{"key":"10.1016\/j.clinthera.2009.10.014_bib38","first-page":"170","article-title":"Consultations for middle ear disease, antibiotic prescribing and risk factors for reattendance: A case-linked cohort study","volume":"56","author":"Williamson","year":"2006","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.clinthera.2009.10.014_bib39","first-page":"379","article-title":"Up-to-date findings show change in acute otitis media consultation trend","volume":"56","author":"Thompson","year":"2006","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.clinthera.2009.10.014_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.5.4.553","article-title":"Pneumococcal conjugate vaccines: Emerging clinical information and its implications","volume":"5","author":"Lockhart","year":"2006","journal-title":"Expert Rev Vaccines."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.10.014_bib42","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0264-410X(00)00284-X","article-title":"Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente","volume":"19","author":"Black","year":"2000","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media [published correction appears in Pediatr Infect Dis J. 2003;22:163]","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.clinthera.2009.10.014_bib44","series-title":"Pneumococcal Vaccines: The Impact of Conjugate Vaccine","article-title":"Correlates of protection","author":"Kohberger","year":"2008"},{"key":"10.1016\/j.clinthera.2009.10.014_bib45","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: A time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2009.10.014_bib46","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneu-mococcal conjugate vaccine on rates of community acquired pneumonia in children and adults","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2009.10.014_bib47","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.clinthera.2009.10.014_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/INF.0b013e3180616715","article-title":"Nontypeable Haemophilus influenzae meningitis in children: Phenotypic and genotypic characterization of isolates","volume":"26","author":"Cardines","year":"2007","journal-title":"Pediatr Infect DisJ."},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.10.014_bib50","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis."},{"key":"10.1016\/j.clinthera.2009.10.014_bib51","first-page":"880","article-title":"National, state, and local area vaccination coverage among children aged 19\u201335 months\u2014United States, 2006","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.clinthera.2009.10.014_bib52","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1128\/JCM.41.7.3064-3069.2003","article-title":"Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas","volume":"41","author":"O\u2019Neill","year":"2003","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.clinthera.2009.10.014_bib53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1469-0691.2008.02028.x","article-title":"Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR","volume":"14","author":"Tarrag\u00f3","year":"2008","journal-title":"Clin Microbiol Infect."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809003713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809003713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:12Z","timestamp":1758962892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809003713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0149291809003713"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.10.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}